Share on LinkedInShare on LinkedIn

ARTICLE · 30 DECEMBER 2021

Note On CCI's Report On The Pharmaceutical Sector

Khurana & Khurana, Advocates and IP Attorneys
Explore more from Khurana & Khurana, Advocates and IP Attorneys

Key findings and observations from a market analysis conducted by the Competition Commission of India (CCI) were revealed on November 18, 2021.

IndiaAntitrust/Competition Law

Key findings and observations from a market analysis conducted by the Competition Commission of India (CCI) were revealed on November 18, 2021.

There are many components of the study, including trade margins, disputes between online and offline distributors, trade associations, and modes of distribution, that are examined. To date, there have been 43 complaints about the pharmaceutical industry to the CCI. Online pharmacies' pricing and competition, as well as branded generic pharmaceuticals' popularity at both wholesale and retail levels and the influence of e-commerce, were all examined as part of a comprehensive inquiry to keep up with the influx of new cases.

In the report, CCI deal with the issues such as:

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from